{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:26:13Z","timestamp":1761006373927,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.healun.2022.12.017","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T02:16:02Z","timestamp":1672107362000},"page":"315-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Natural killer cells, CMV infection, and antibody-mediated rejection"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-512X","authenticated-orcid":false,"given":"P.","family":"Riddell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7243-556X","authenticated-orcid":false,"given":"S.C.","family":"Juvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2022.12.017_bib0001","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.humimm.2012.07.330","article-title":"Role of complement and NK cells in antibody mediated rejection","volume":"73","author":"Akiyoshi","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2022.12.017_bib0002","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/thoraxjnl-2018-212345","article-title":"Natural killer cells in lung transplantation","volume":"74","author":"Calabrese","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2022.12.017_bib0003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/eji.1830050209","article-title":"\"Natural\" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.healun.2022.12.017_bib0004","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.1997.tb00953.x","article-title":"Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes","volume":"155","author":"Renard","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.healun.2022.12.017_bib0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.immuni.2008.06.012","article-title":"Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function","volume":"29","author":"Maroof","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.healun.2022.12.017_bib0006","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/ajt.14295","article-title":"HLA mismatching favoring host-versus-graft NK cell activity via KIR3DL1 is associated with improved outcomes following lung transplantation","volume":"17","author":"Greenland","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.12.017_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MOT.0b013e32834254cf","article-title":"Natural killer cells in rejection and tolerance of solid organ allografts","volume":"16","author":"Benichou","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.healun.2022.12.017_bib0008","doi-asserted-by":"crossref","first-page":"8864","DOI":"10.3390\/ijms21228864","article-title":"Deciphering the immunological phenomenon of adaptive natural killer (NK) cells and cytomegalovirus (CMV)","volume":"21","author":"Barnes","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.healun.2022.12.017_bib0009","unstructured":"Vietzen H, Jaksch P, Puchhammer-St\u00f6ckl E. The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients. J Heart Lung Transplant."},{"key":"10.1016\/j.healun.2022.12.017_bib0010","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/eji.201546179","article-title":"Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans","volume":"46","author":"Bayard","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.healun.2022.12.017_bib0011","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.kint.2018.08.027","article-title":"Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation","volume":"95","author":"Yazdani","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.healun.2022.12.017_bib0012","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1111\/ajt.16690","article-title":"The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation","volume":"21","author":"Lin","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.12.017_bib0013","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.12.017_bib0014","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.healun.2015.08.021","article-title":"Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies","volume":"35","author":"Wallace","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.12.017_bib0015","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.healun.2014.06.006","article-title":"Reproducibility of complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies","volume":"33","author":"Roden","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.12.017_bib0016","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOT.0b013e3283352a50","article-title":"Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection","volume":"15","author":"Sis","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.healun.2022.12.017_bib0017","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.healun.2019.01.1317","article-title":"Molecular assessment of rejection and injury in lung transplant biopsies","volume":"38","author":"Halloran","year":"2019","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822022732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822022732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:47:12Z","timestamp":1760950032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249822022732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1053249822022732"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2022.12.017","relation":{},"ISSN":["1053-2498"],"issn-type":[{"type":"print","value":"1053-2498"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cells, CMV infection, and antibody-mediated rejection","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2022.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}